Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Meridian Bioscience, Inc. (VIVO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.24+0.15 (+0.75%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close20.09
Open19.94
Bid20.24 x 800
Ask20.25 x 1300
Day's Range19.67 - 20.28
52 Week Range17.00 - 30.65
Volume349,929
Avg. Volume334,652
Market Cap876.999M
Beta (5Y Monthly)0.42
PE Ratio (TTM)10.12
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateFeb 01, 2019
1y Target EstN/A
  • Motley Fool

    Meridian Bioscience Inc (VIVO) Q4 2021 Earnings Call Transcript

    Image source: The Motley Fool. Meridian Bioscience Inc (NASDAQ: VIVO)Q4 2021 Earnings CallNov 12, 2021, 10:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGreetings.

  • Benzinga

    Meridian Bioscience's Q4 Earnings Beat Expectations

    View more earnings on VIVOSee more from BenzingaClick here for options trades from BenzingaGSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19Labcorp In Talks To Merge Some Covance Assets With Syneos: Bloomberg© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Zacks

    Meridian Bioscience (VIVO) Earnings Expected to Grow: Should You Buy?

    Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Advertisement
Advertisement